Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Am Heart J. 2020 Apr 20;226:161–173. doi: 10.1016/j.ahj.2020.04.010

Table III:

RE-AIM Framework

Conceptual Area Definition Measurement in DECIDE-ICD
Reach Proportion and representativeness of the target population who participate in the intervention. The number of patients who receive and remember the PtDA; over the number of patients eligible for ICD, replacement, or CRT-D.
Comparison to those not participating.
Effectiveness The impact of an intervention on important outcomes and any unanticipated outcomes. Domains of decision quality: 1) knowledge and 2) value-choice concordance; will be measured by participant questionnaires.
Adoption Proportion and representativeness of staff who are willing to initiate a program. Clinician attitudes toward SDM and the intervention will be measured in pre/post interviews and a 6 question per-patient survey for each patient enrolled. Comparison to those not participating.
Implementation How closely staff members follow the program that the developers provide, and adaptations made. Interviews with clinicians pre-, during, and post-intervention will measure implementation of SDM with PtDA. Additionally, a study coordinator checklist for patients will measure implementation and adaptation.
Maintenance The extent to which a program or policy becomes part of the routine organizational practices and policies. This will be assessed primarily by seeing whether each of the 6 sites decides at the conclusion of the study to maintain, modify, or discontinue the PtDAs.